Christine Fox
Evp, Head Of U.S. Commercial at Teva Pharmaceutical Industries Ltd (TEVA); Evp, U.S. Commercial at Teva Pharmaceutical Industries Ltd (TEVA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 4SEC | TEVATeva Pharmaceutical Industries Ltd | Sell | 21,25863,647 held (−25%) | $35.31 | $751K | +16.4% |
| Mar 9SEC | TEVATeva Pharmaceutical Industries Ltd | Sell Plan | 7,92484,905 held (−9%) | $31.67 | $251K | +29.8% |
| Mar 6SEC | TEVATeva Pharmaceutical Industries Ltd | Sell Plan | 9,09875,010 held (−11%) | $32.46 | $295K | +26.6% |
| Nov 24SEC | TEVATeva Pharmaceutical Industries Ltd | Sell Plan | 28,22963,647 held (−31%) | $24.78 | $700K | +65.9% |
| Nov 18SEC | TEVATeva Pharmaceutical Industries Ltd | Sell | 30,00028,384 held (−51%) | $25.11 | $753K | +63.7% |
- Sell
Evp, U.S. Commercial Christine Fox sold $751K of TEVA at $35.31 — cuts the stake by 25%.
- Sell
Evp, U.S. Commercial Christine Fox sold $251K of TEVA at $31.67 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, U.S. Commercial Christine Fox sold $295K of TEVA at $32.46 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Head Of U.S. Commercial Christine Fox sold $700K of TEVA at $24.78 — cuts the stake by 31%; pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Head Of U.S. Commercial Christine Fox sold $753K of TEVA at $25.11 — cuts the stake by 51%.